ALTEOGEN Inc. (KOSDAQ:196170)
South Korea · Delayed Price · Currency is KRW 439,000
+9,000 (2.09%)
At close: Dec 26, 2025
ALTEOGEN Market Cap
ALTEOGEN has a market cap or net worth of 23.48 trillion as of December 26, 2025. Its market cap has increased by 45.63% in one year.
Market Cap
23.48T
Enterprise Value
23.23T
Revenue
202.18B
Ranking
n/a
PE Ratio
193.99
Stock Price
439,000.00
Market Cap Chart
Since December 12, 2014, ALTEOGEN's market cap has increased from 119.96B to 23.48T, an increase of 19,472.76%. That is a compound annual growth rate of 61.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 23.48T | 42.34% |
| Dec 30, 2024 | 16.49T | 221.05% |
| Dec 28, 2023 | 5.14T | 160.78% |
| Dec 29, 2022 | 1.97T | -38.41% |
| Dec 30, 2021 | 3.20T | -36.62% |
| Dec 30, 2020 | 5.05T | 442.81% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 78.32T |
| Celltrion | 39.38T |
| ABL Bio | 10.97T |
| SK Biopharmaceuticals | 9.80T |
| Yuhan | 8.41T |
| LigaChem Biosciences | 6.55T |
| HLB Co., Ltd. | 6.06T |
| Hanmi Pharm. | 5.71T |